Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia

NCT05899842 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Achalasia

Interventions

DRUG: Protein pump inhibitor therapy systematically

Sponsor

Centre Hospitalier Universitaire de Nīmes